Translation and Validation of Chinese COMPAT-SF

Launched by CHANGHAI HOSPITAL · Apr 2, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on creating and testing a Chinese version of a questionnaire called the Comprehensive Pain Assessment Tool Short Form (COMPAT-SF). The goal is to see if this tool effectively measures pain for people suffering from chronic pancreatitis, a condition that causes ongoing pain in the pancreas. The study will help doctors in China better understand and treat pain in patients with this condition by ensuring the tool is accurate and reliable over time.

To participate, you must be diagnosed with chronic pancreatitis and have experienced pancreatic pain in the last year. If you join the study, you'll fill out the Chinese COMPAT-SF questionnaire twice, with two weeks in between, and answer some additional questions about your pain. This will help researchers determine if the questionnaire provides consistent results. The trial is open to adults aged 18 and older, and it aims to support better pain management for those living with chronic pancreatitis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosed with chronic pancreatitis (CP) according to the Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis in China (2018 edition). Diagnosis can be confirmed by: •Primary diagnostic criteria: (i) Definitive imaging findings, and (ii) Histopathological confirmation. •Secondary diagnostic criteria: (i) Recurrent upper abdominal pain, (ii) Abnormal serum amylase levels, (iii) Pancreatic exocrine insufficiency, (iv) Pancreatic endocrine insufficiency, (v) Pathogenic gene mutations, and (vi) History of heavy alcohol consumption. •Diagnosis is confirmed if at least one primary criterion or two secondary criteria are met.
• • 2. Experience of pancreatic pain in the past 12 months
• Exclusion Criteria:
• • Under 18 years of age.
• • No pancreatic-related pain.
• • Diagnosed with pancreatic cancer or other tumors.
• • Presence of communication or reading impairments.
• • Refusal to participate in the study.